Related Experiment Video

Updated: Oct 6, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.9K

Gene Therapy for Huntington's Disease: The Future Is in Gene Editing

Ana Rita Batista1

  • 1Department of Neurology, Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Human Gene Therapy
|January 20, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

8.1K
Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

2.7K

Related Experiment Videos

Last Updated: Oct 6, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.9K
Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

8.1K
Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

2.7K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

26.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.1K
What is Genetic Engineering?00:49

What is Genetic Engineering?

76.0K
Overview
76.0K
CRISPR01:59

CRISPR

53.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.3K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

14.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.9K

Articles linked to this work by shared authors, journal, and citation graph.

AAV-mediated gene therapy demonstrates phenotypic rescue in a mouse model of Cockayne Syndrome.

The Journal of clinical investigation·2026

Five-year analysis of efficacy and safety of a bidirectional AAV gene therapy in Tay-Sachs sheep.

The Journal of clinical investigation·2025

Intrastriatal Delivery of a Zinc Finger Protein Targeting the Mutant HTT Gene Allele Obviates Lipid Phenotypes in Brain and Plasma in Huntington's Disease Mice.

Human gene therapy·2025

Is It About Speech or About Prediction? Testing Between Two Accounts of the Rhythm-Reading Link.

Brain sciences·2025

More than a Bundle? Developing Adaptive Guidance for Task Selection in an Online, Semantic-Based Cognitive Stimulation Program.

Brain sciences·2025

Adults With Dyslexia Use Internalised Beat Cues Less Than Controls When Estimating Interval Length.

Dyslexia (Chichester, England)·2025

Engineering Human Hematopoietic Stem and Progenitor Cells for Antigen Expression in Antigen-Presenting Cells.

Human gene therapy·2026

Triple-Target CRISPR Strategy to Block HIV Entry and Replication in Permissive Cells.

Human gene therapy·2026

Perivascular Astrocytic Gliosis Induced by Retinal Gene Therapy.

Human gene therapy·2026

Durational Study of Persistent Transduction of Rhesus Macaque Lung and Other Organs Following Single Dosing with AAV1-CFTR.

Human gene therapy·2026

Real-World Data from a Single-Center, Large Academic Centralized Manufacturing of CD19 CAR T Cells in an Industry Partnership.

Human gene therapy·2026

Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective.

Human gene therapy·2026

PUM1 Promotes HCC Cell Proliferation and Inhibits Mitochondria‑mediated Apoptosis, Accompanied by Activation of the PI3K-AKT Pathway.

Journal of hepatocellular carcinoma·2026

Breaking the antimicrobial resistance dilemma: marine natural products, a treasure trove for the development of new anti-Staphylococcus aureus drugs.

Marine life science & technology·2026

Optimizing plasma-derived small extracellular vesicle purification to enhance downstream applications.

iScience·2026

Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems.

International journal of pharmaceutics: X·2026

N-Terminal polarity reversal of cysteine-terminated peptides: A strategy to develop potent metallo-β-lactamase inhibitors with in vivo efficacy.

European journal of medicinal chemistry·2026

Non-Oncology Biomarkers in Precision Medicine: A Narrative Review.

Therapeutic innovation & regulatory science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us